Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$9.02 - $10.29 $243 - $277
-27 Reduced 0.13%
20,428 $203,000
Q1 2023

May 12, 2023

SELL
$9.2 - $12.26 $8,289 - $11,046
-901 Reduced 4.22%
20,455 $196,000
Q4 2022

Feb 14, 2023

BUY
$8.72 - $11.56 $12,007 - $15,918
1,377 Added 6.89%
21,356 $237,000
Q3 2022

Nov 14, 2022

SELL
$8.48 - $11.13 $69,841 - $91,666
-8,236 Reduced 29.19%
19,979 $170,000
Q2 2022

Aug 15, 2022

BUY
$9.95 - $12.27 $5,303 - $6,539
533 Added 1.93%
28,215 $295,000
Q1 2022

May 11, 2022

BUY
$9.81 - $15.4 $12,978 - $20,374
1,323 Added 5.02%
27,682 $301,000
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $51,588 - $62,639
-4,267 Reduced 13.93%
26,359 $357,000
Q3 2021

Nov 15, 2021

SELL
$13.25 - $15.13 $18,589 - $21,227
-1,403 Reduced 4.38%
30,626 $415,000
Q2 2021

Aug 16, 2021

BUY
$12.97 - $16.15 $6,407 - $7,978
494 Added 1.57%
32,029 $458,000
Q1 2021

May 17, 2021

SELL
$13.59 - $18.54 $28,240 - $38,526
-2,078 Reduced 6.18%
31,535 $441,000
Q4 2020

Feb 11, 2021

BUY
$14.3 - $18.74 $480,665 - $629,907
33,613 New
33,613 $630,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $11.5B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Veritable, L.P. Portfolio

Follow Veritable, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Veritable, L.P. with notifications on news.